يعرض 1 - 10 نتائج من 262 نتيجة بحث عن '"Veal, Gareth J"', وقت الاستعلام: 1.45s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://eprints.gla.ac.uk/323722/2/323722.pdfTest; Spiliopoulou, P. et al. (2024) A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301). Journal of Experimental and Clinical Cancer Research , 43(1), 100. (doi:10.1186/s13046-024-03010-1 ) (PMID:38566164) (PMCID:PMC10986017)

  4. 4
    دورية أكاديمية
  5. 5
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://orca.cardiff.ac.uk/id/eprint/159492/1/JONES%20ROBERT%20-%20A%20Phase%2012%20trial%20of%20SRA737%20%28a%20Chk1%20inhibitor%29%20administered%20orally%20in%20patients%20with%20advanced%20cancer.pdfTest; Kristeleit, Rebecca, Plummer, Ruth, Jones, Robert https://orca.cardiff.ac.uk/view/cardiffauthors/A007428W.htmlTest orcid:0000-0003-3576-9496 orcid:0000-0003-3576-9496, Carter, Louise, Blagden, Sarah, Sarker, Debashis, Arkenau, Tobias, Evans, Thomas R. Jeffry, Danson, Sarah, Symeonides, Stefan N., Veal, Gareth J., Klencke, Barbara J., Kowalski, Mark M. and Banerji, Udai 2023. A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer. British Journal of Cancer 10.1038/s41416-023-02279-x https://doi.org/10.1038/s41416-023-02279-xTest file https://orca.cardiff.ac.uk/id/eprint/159492/1/JONES%20ROBERT%20-%20A%20Phase%2012%20trial%20of%20SRA737%20%28a%20Chk1%20inhibitor%29%20administered%20orally%20in%20patients%20with%20advanced%20cancer.pdfTest

  8. 8
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية